Biblio
Export 1190 results:
Author [ Title] Type Year Filters: First Letter Of Last Name is D [Clear All Filters]
“Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1279-1292, 2017.
, “Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1279-1292, 2017.
, “Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1633-1640, 2017.
, “Sex Differences in the Psychophysical Response to Contact Heat in Moderate Cognitive Impairment Alzheimer's Disease: A Cross-Sectional Brief Report.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1633-1640, 2017.
, “Sex Difference in Aerobic Exercise Efficacy to Improve Cognition in Older Adults with Vascular Cognitive Impairment: Secondary Analysis of a Randomized Controlled Trial.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1397-1410, 2017.
, “Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1439-1448, 2017.
, “Severity of Depression Impacts Imminent Conversion from Mild Cognitive Impairment to Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1439-1448, 2017.
, “Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.”, J Alzheimers Dis, vol. 79, no. 2, pp. 807-817, 2020.
, “Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.”, J Alzheimers Dis, vol. 81, no. 1, pp. 389-401, 2021.
, “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.
, “Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1123-1130, 2017.
, “Serum Insulin-Like Growth Factor I Deficiency Associates to Alzheimer's Disease Co-Morbidities.”, J Alzheimers Dis, vol. 69, no. 4, pp. 979-987, 2019.
, “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
, “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
, “Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.”, J Alzheimers Dis, vol. 65, no. 3, pp. 793-806, 2018.
, “Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.”, J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
, “Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, 2024.
, “Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1187-1202, 2017.
, “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
, “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
, “Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).”, J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
, “Self-Reported Traumatic Brain Injury and Mild Cognitive Impairment: Increased Risk and Earlier Age of Diagnosis.”, J Alzheimers Dis, vol. 51, no. 3, pp. 727-36, 2016.
, “Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1299-1305, 2018.
, “Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.”, J Alzheimers Dis, vol. 55, no. 2, pp. 749-762, 2017.
, “Selective Peripheral Taste Dysfunction in APP/PS1 Mutant Transgenic Mice.”, J Alzheimers Dis, 2020.
,